Medicamento contra colesterol da Merck atinge objetivo principal em ensaio clínico head-to-head https://www.reuters.com/business/healthcare-pharmaceuticals/mercks-drug-reduced-bad-cholesterol-by-646-late-stage-trial-2026-03-30/?taid=69cae7de1de6e000018af757 https://www.reuters.com/business/healthcare-pharmaceuticals/mercks-drug-reduced-bad-cholesterol-by-646-late-stage-trial-2026-03-30/?taid=69cae7de1de6e000018af757